Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT05797246 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT05797246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05797246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 2, 2023
Completion date
January 1, 2029
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disease attributes, dna virus infections, infections, neoplasms, neoplasms by histologic type, neoplasms, glandular and epithelial, neoplasms, squamous cell, papilloma, papillomavirus infections, pathologic processes, recurrence, respiratory tract diseases, respiratory tract infections, tumor virus infections, virus diseases